Read More 2 minute read Hiring News News Therapeutics MOMA Therapeutics Welcomes New Leadership Team Members Key Highlights Marc Ballas, M.D. appointed as SVP, head of clinical development. Adam Thomas joins as chief people and experience… byChris-Anne RoqueJune 28, 2024
Read More 1 minute read Hiring News News Lokavant Expands Advisory Board, Welcomes New AI Exec Key Highlights Jonathan Crowther, Pfizer’s Head of Predictive Analytics, joins Lokavant Advisory Board. Aaron Mackey, PhD, appointed as… byChris-Anne RoqueMay 8, 2024
Read More 1 minute read Hiring News News Andrew Baum Joins Pfizer as Chief Strategy Officer Key Highlights Dr. Andrew Baum appointed as Chief Strategy and Innovation Officer, EVP, reporting to CEO Dr. Albert Bourla.… byChris-Anne RoqueMay 7, 2024
Read More 2 minute read Hiring News News Zura Bio Appoints New CEO: Robert Lisicki Key Highlights Robert Lisicki assumes the role of CEO and Director at Zura Bio, succeeding founding CEO, Dr. Someit Sidhu. Zura… byChris-Anne RoqueApril 11, 2024
Read More 2 minute read Hiring News News Odyssey Therapeutics Bolsters Leadership Team Key Highlights Julie Clauss, MBA, appointed as Chief Operating Officer, bringing extensive biotech and pharmaceutical leadership experience. Christopher… byChris-Anne RoqueApril 4, 2024
Read More 1 minute read Hiring News News Mosaic Biosciences Bolsters Leadership Team Key Highlights Mosaic Biosciences welcomes Dr. Malavi Madireddi and Dr. Scott Glaser as Senior Vice Presidents in Drug and Biologics Discovery, respectively. Both… byChris-Anne RoqueApril 4, 2024
Read More 2 minute read Hiring News News NTx Welcomes New CSO Steven Evans Key Highlights Steven Evans, Ph.D., appointed as Chief Scientific Officer and Senior Vice President of R&D at Nature’s Toolbox… byChris-Anne RoqueMarch 1, 2024
Read More 1 minute read Hiring News News Marc Yoskowitz Takes Helm as CEO at Evozyne to Propel AI-Driven Drug Discovery Key Highlights Marc Yoskowitz appointed as CEO of Evozyne, bringing extensive leadership from Tempus AI, Pfizer, and McKinsey.… byChris-Anne RoqueJanuary 9, 2024